XpertFlow Technologies Pte. Ltd. Company Profile

Background

Overview

XpertFlow Technologies Pte. Ltd. is a Singapore-based health technology company specializing in AI-driven preventive healthcare solutions. Founded in 2020, the company focuses on early detection of life-threatening conditions, such as heart attacks and strokes, by integrating advanced biosensor technology with artificial intelligence. Their flagship product, Welltronica™, is an AI-powered health kiosk designed to predict critical medical events weeks before symptoms appear, thereby enabling proactive healthcare interventions.

Mission and Vision

XpertFlow's mission is to revolutionize healthcare by providing accessible, real-time health monitoring solutions that empower individuals and organizations to take proactive measures in managing health risks. Their vision is to create a world where preventable diseases are identified and addressed before they escalate, leading to improved health outcomes and reduced healthcare costs.

Industry Significance

Operating within the health technology sector, XpertFlow addresses the critical need for preventive healthcare solutions. By leveraging AI and biosensor technologies, the company contributes to the global shift towards proactive health management, aiming to reduce the burden of chronic diseases and enhance the efficiency of healthcare delivery systems.

Key Strategic Focus

Core Objectives

Early Detection: Utilize AI and biosensor technologies to identify early signs of life-threatening conditions.

Proactive Healthcare: Enable individuals and organizations to take preventive measures, reducing the incidence of medical emergencies.

Scalability: Develop solutions that can be widely implemented across various healthcare settings, including workplaces and clinics.

Areas of Specialization

Preventive Health Monitoring: Continuous assessment of vital signs to detect potential health risks.

AI Integration: Employ machine learning algorithms to analyze health data and predict medical events.

Biosensor Technology: Design and deploy wearable devices and kiosks for real-time health data collection.

Key Technologies Utilized

Artificial Intelligence: For data analysis, pattern recognition, and predictive modeling.

Biosensors: To monitor physiological parameters such as heart rate, blood pressure, and ECG.

Cloud Computing: For data storage, processing, and remote access to health information.

Primary Markets Targeted

Corporate Wellness Programs: Offering health monitoring solutions to employers for employee well-being.

Healthcare Providers: Supplying clinics and hospitals with tools for patient monitoring and early diagnosis.

Insurance Companies: Providing data-driven insights to inform health insurance policies and risk assessments.

Financials and Funding

Funding History

XpertFlow has raised a total of $120,000 in seed funding. The most recent funding round occurred on July 25, 2022, with a raise of $100,000.

Notable Investors

The company has attracted investment from various entities, including:

QDB Incubation & Acceleration: A program by Qatar Development Bank supporting innovative startups.

AWS ISV Accelerate Program: Amazon Web Services' program for Independent Software Vendors.

AWS Generative AI Spotlight APJ Program: A program focusing on generative AI solutions in the Asia-Pacific region.

AWS Jumpstart Program: An initiative by AWS to support early-stage startups.

Utilization of Capital

The raised funds are primarily allocated towards:

Product Development: Enhancing the capabilities and features of Welltronica™.

Market Expansion: Scaling operations to reach a broader customer base.

Research and Development: Investing in AI and biosensor technology advancements.

Pipeline Development

Key Pipeline Candidates

Welltronica™ Health Kiosks: AI-powered kiosks designed for real-time health screenings and early detection of critical conditions.

NWear Biosensor: A wearable device that continuously monitors vital signs and transmits data for analysis.

Stages of Development

Welltronica™ Health Kiosks: Fully developed and operational, with successful pilot projects completed in June 2025.

NWear Biosensor: Currently in the prototype stage, with plans for clinical trials in the coming year.

Target Conditions

Heart Attacks: Predicting and preventing cardiac events through early detection.

Strokes: Identifying risk factors and signs to prevent cerebrovascular incidents.

Chronic Diseases: Monitoring and managing conditions such as hypertension and diabetes.

Anticipated Milestones

Product Launches: Full-scale deployment of Welltronica™ kiosks in corporate and healthcare settings.

Clinical Trials: Initiation of trials for NWear biosensor to validate efficacy and safety.

Technological Platform and Innovation

Proprietary Technologies

Welltronica™ Platform: An integrated system combining hardware (health kiosks) and software (AI algorithms) for preventive health monitoring.

NWear Biosensor: A wearable device equipped with sensors to collect physiological data for analysis.

Significant Scientific Methods

Deep Learning Algorithms: Utilized for analyzing complex health data and predicting medical events.

Predictive Analytics: Employed to assess health risks and provide actionable insights.

AI-Driven Capabilities

Real-Time Data Processing: Enables immediate analysis of health metrics for prompt decision-making.

Pattern Recognition: Identifies anomalies and potential health risks from continuous monitoring data.

Leadership Team

Rashid Hameed – Founder & CEO

An Electronics Engineer with over 10 years of experience in IT, Telecom, and Healthcare industries. Hameed has a BE in Electronics Engineering and an MS in Engineering Management. He has previously founded three startups and has extensive experience in business development, pre-sales, and project management.

Sayyaf Haider Warraich – Co-Founder & COO

Holding an MS and BE in Electrical Engineering, Warraich has seven years of experience in the Telecom and Healthcare IT industries, specializing in cybersecurity. He has managed operations in both corporate and startup environments.

Shan Haq – Co-Founder & CTO

With a BE in Electrical Engineering, Haq specializes in Embedded Systems, AI, Mechanical Modeling, and IoT technologies. He has over seven years of experience in technical roles and has previously founded two startups.

See Ting – Co-Founder & CCO

Ting holds a Master of Technology in Knowledge Engineering (Machine Learning) from the National University of Singapore. He manages the company's headquarters in Singapore and fosters strategic partnerships to advance XpertFlow's vision.

Leadership Changes

As of December 2025, there have been no significant changes or appointments within XpertFlow's leadership team.

Competitor Profile

Market Insights and Dynamics

The global health technology market is experiencing rapid growth, driven by increasing health awareness, technological advancements, and the need for cost-effective healthcare solutions. Preventive healthcare is gaining traction as a means to reduce the burden of chronic diseases and improve overall health outcomes.

Competitor Analysis

XpertFlow operates in a competitive landscape with several key players:

Qure.ai: Specializes in AI-driven medical imaging solutions for diagnostics.

Predictmedix AI: Focuses on AI-based health screening technologies.

Shen AI: Develops AI solutions for healthcare applications.

Strategic Collaborations and Partnerships

XpertFlow has engaged in strategic partnerships to enhance its market position and innovation capacity:

SIMTech (A*Star): Collaborated to advance XpertFlow's vision in the region.

AWS Programs: Participated in various AWS initiatives to support product development and scalability.

Operational Insights

XpertFlow differentiates itself through its integrated approach, combining hardware and AI-driven software to provide comprehensive preventive health solutions. This holistic strategy positions the company to effectively address the growing demand for proactive healthcare interventions.